Haiquan Chen MDProfessor of Oncology, Department of Thoracic Surgery, Fudan University Shanghai Cancer Hospital, Shanghai, China
Dr. Haiquan Chen is a Professor of Oncology at the Department of Thoracic Surgery of Fudan University Shanghai Cancer Hospital. His main research themes are identifying therapeutic targets in lung cancer and clarifying the mechanism of treatment resistance and strategies to overcome them.
Prof. Chen has published over 50 papers on his research interests. His research team has determined the unique oncogenic mutation spectrums of Chinese patients including lung squamous carcinomas, adenosquamous cell carcinomas, and especially adenocarcinomas and never-smoking lung adenocarcinomas. They were one of the teams that first revealed ROS1 and RET fusion gene in lung cancer, which are currently well-known as targetable biomarkers. Their current interest is focused on identifying the mechanism of treatment resistance and strategies to overcome them.
Dr. Chen is an active member of AATS (American Association for Thoracic Surgery). He is also a vice Editor-in-Chief of Journal of Cancer Research and Clinical Oncology that focuses on translational research in oncology.